This is a Validated Antibody Database (VAD) review about cow TGFB1, based on 5 published articles (read how Labome selects the articles), using TGFB1 antibody in all methods. It is aimed to help Labome visitors find the most suited TGFB1 antibody. Please note the number of articles fluctuates since newly identified citations are added and citations for discontinued catalog numbers are removed regularly.
TGFB1 synonym: transforming growth factor beta-1; TGF-beta-1; transforming growth factor, beta 1 (Camurati-Engelmann disease)

Bio X Cell
mouse monoclonal (1D11.16.8)
  • blocking or activating experiments; mouse; loading ...; fig 1l
Bio X Cell TGFB1 antibody (BioXcell, 1D11.16.8) was used in blocking or activating experiments on mouse samples (fig 1l). J Exp Med (2017) ncbi
Abcam
mouse monoclonal (TB21)
  • western blot; mouse; 1:500; fig 4
Abcam TGFB1 antibody (Abcam, ab190503) was used in western blot on mouse samples at 1:500 (fig 4). Int J Mol Med (2016) ncbi
Invitrogen
mouse monoclonal (TB21)
  • blocking or activating experiments; human
In order to measure TGF-beta, IL-10, and IFN-gamma production by peripheral blood mononuclear cells of unexposed naive subjects and LCL patients after stimulation with live Leishmania guyanensis, Invitrogen TGFB1 antibody (Biosource, TB21) was used in blocking or activating experiments on human samples . Microbes Infect (2007) ncbi
mouse monoclonal (TB21)
  • blocking or activating experiments; human
In order to show that TGF-beta1 is involved in the suppressive activity of Leishmania guyanensis-stimulated CD4+ CD25+ T cells from healthy controls, Invitrogen TGFB1 antibody (Biosource, TB21) was used in blocking or activating experiments on human samples . Infect Immun (2005) ncbi
Bio-Rad
mouse monoclonal (TB21)
  • immunohistochemistry; human; 1:100; loading ...; fig 1c
Bio-Rad TGFB1 antibody (AbD Serotec, MCA797) was used in immunohistochemistry on human samples at 1:100 (fig 1c). BMC Cancer (2015) ncbi
Articles Reviewed
  1. Daley D, Mani V, Mohan N, Akkad N, Pandian G, Savadkar S, et al. NLRP3 signaling drives macrophage-induced adaptive immune suppression in pancreatic carcinoma. J Exp Med. 2017;214:1711-1724 pubmed publisher
  2. Hou C, Wu Q, Ouyang C, Huang T. Effects of an intravitreal injection of interleukin-35-expressing plasmid on pro-inflammatory and anti-inflammatory cytokines. Int J Mol Med. 2016;38:713-20 pubmed publisher
  3. Kassem L, Deygas M, Fattet L, Lopez J, Goulvent T, Lavergne E, et al. TIF1γ interferes with TGFβ1/SMAD4 signaling to promote poor outcome in operable breast cancer patients. BMC Cancer. 2015;15:453 pubmed publisher
  4. Bourreau E, Ronet C, Couppie P, Sainte Marie D, Tacchini Cottier F, Launois P. IL-10 producing CD8+ T cells in human infection with Leishmania guyanensis. Microbes Infect. 2007;9:1034-41 pubmed
  5. Kariminia A, Bourreau E, Pascalis H, Couppie P, Sainte Marie D, Tacchini Cottier F, et al. Transforming growth factor beta 1 production by CD4+ CD25+ regulatory T cells in peripheral blood mononuclear cells from healthy subjects stimulated with Leishmania guyanensis. Infect Immun. 2005;73:5908-14 pubmed